SARRECCHIA, CESARE
 Distribuzione geografica
Continente #
NA - Nord America 11.182
EU - Europa 1.209
AS - Asia 1.135
SA - Sud America 177
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 13.729
Nazione #
US - Stati Uniti d'America 11.151
SG - Singapore 579
CN - Cina 265
IT - Italia 180
DE - Germania 156
UA - Ucraina 148
BR - Brasile 146
RU - Federazione Russa 123
FR - Francia 121
PL - Polonia 99
SE - Svezia 97
IE - Irlanda 89
VN - Vietnam 83
FI - Finlandia 82
HK - Hong Kong 70
GB - Regno Unito 54
KR - Corea 31
JP - Giappone 29
IN - India 15
BD - Bangladesh 14
CA - Canada 13
CZ - Repubblica Ceca 13
MX - Messico 13
AR - Argentina 11
BE - Belgio 11
ID - Indonesia 8
NL - Olanda 8
TR - Turchia 8
ES - Italia 7
ZA - Sudafrica 7
AU - Australia 5
CH - Svizzera 5
EC - Ecuador 5
IQ - Iraq 5
AT - Austria 4
CL - Cile 4
CO - Colombia 4
SA - Arabia Saudita 4
A2 - ???statistics.table.value.countryCode.A2??? 3
MA - Marocco 3
NP - Nepal 3
PY - Paraguay 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
EG - Egitto 2
EU - Europa 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
PH - Filippine 2
PK - Pakistan 2
TW - Taiwan 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
KN - Saint Kitts e Nevis 1
LT - Lituania 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
TN - Tunisia 1
VA - Santa Sede (Città del Vaticano) 1
VI - Stati Uniti Isole Vergini 1
Totale 13.729
Città #
Woodbridge 3.207
Wilmington 2.823
Houston 2.498
Fairfield 364
Singapore 345
Chandler 268
Ann Arbor 221
Ashburn 219
Seattle 138
San Jose 120
Cambridge 116
Jacksonville 116
Beijing 98
Kraków 85
Dublin 84
Rome 80
New York 71
Hong Kong 67
Medford 63
Dearborn 62
Helsinki 53
Santa Clara 50
Zhengzhou 47
Los Angeles 41
The Dalles 41
Milan 33
Lawrence 29
Council Bluffs 28
Ho Chi Minh City 28
Tokyo 24
Hanoi 23
Lauterbourg 23
Munich 22
São Paulo 22
Menlo Park 20
San Diego 18
San Francisco 16
Moscow 15
Boardman 14
Palo Alto 14
Redondo Beach 13
Shanghai 13
Chicago 12
Mülheim 12
Phoenix 12
Warsaw 12
Brussels 11
Buffalo 11
Nanjing 11
Orem 11
London 10
Verona 10
Stockholm 9
Creede 8
Dallas 8
Falls Church 8
Jakarta 8
Brno 7
Denver 7
Montreal 7
Nuremberg 7
Amsterdam 6
Ankara 6
Belo Horizonte 6
Boston 6
Dong Ket 6
Hefei 6
Olomouc 6
Rio de Janeiro 6
Schiffdorf 6
Atlanta 5
Brooklyn 5
Johannesburg 5
Kunming 5
Manchester 5
Poplar 5
Redwood City 5
University Park 5
Charlotte 4
Chennai 4
Dhaka 4
Frankfurt am Main 4
Guangzhou 4
Madrid 4
Nanchang 4
Southport 4
Anápolis 3
Auburn Hills 3
Brasília 3
Chengdu 3
Colorado Springs 3
Curitiba 3
Honolulu 3
Jinan 3
Lausanne 3
Mountain View 3
Riyadh 3
Ahmedabad 2
Amman 2
Araraquara 2
Totale 11.978
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 577
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice 507
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 487
Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanisms. 485
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 484
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 484
Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs. 478
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 473
Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection 472
HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb 467
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. 467
Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis 464
HIV plasma viremia in 22 seropositive subjects [VALUTAZIONE DELLA VIREMIA PLASMATICA DA HIV IN 22 SOGGETTI SIERO-POSITIVI] 460
Optimal efficacy of interferon-free HCV retreatment after protease inhibitors failure in real life. 457
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors 452
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. 450
Multidrug resistance after lamivudine therapy for chronic hepatitis B 449
Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection 447
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen 431
Aciclovir, herpes viruses and HIV: a never-ending story 427
Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy 421
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance 420
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. 399
Two-year surveillance on fluconazole susceptibility of Candida spp isolates in a general and university hospital in Rome. 395
Interstitial pulmonary fibrosis in chronic HCV hepatitis treated with interferon 393
Novel reverse transcriptase mutations specifically associated with selected anti-Hbv treatment can induce alterations and stop-codons in Hbv S antigen 392
Epidemiological burden estimates for pathologies with a non constant risk: an application to HCV in Italy according to age, Metavir score, and genotype 390
High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance 379
Long-term intramuscular teicoplanin treatment of chronic osteomyelitis due to oxacillin-resistant Staphylococcus aureus in outpatients 377
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection 353
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 297
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 99
Evaluation of the antibody response to EBNA-1 in EBV infections | VALIDITA DELLA RICERCA DEGLI ANTICORPI ANTI EBNA-1 NELLA DIAGNOSTICA DELLE INFEZIONI DA EBV 80
Therapy and prevention of infective endocarditis 38
Totale 13.851
Categoria #
all - tutte 28.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.889


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021133 0 0 0 0 0 0 0 0 0 50 64 19
2021/2022441 24 36 36 22 4 32 21 13 103 33 15 102
2022/2023608 54 65 54 92 41 118 35 54 51 7 25 12
2023/2024200 31 2 11 4 6 66 0 14 4 8 0 54
2024/2025795 24 170 95 44 48 30 61 34 121 61 55 52
2025/20261.280 97 57 137 156 128 53 276 127 161 88 0 0
Totale 13.851